Maker of Naloxone issues recall due to ‘loose particulate matter’

Leslie Hanson
June 7, 2018

The drug is now commonly carried by first responders and family members of opioid painkiller and heroin addicts as it can reverse deadly overdose symptoms like the inability to breathe.

Naloxone manufacturer Hospira issued a voluntary recall of its single-use cartridge syringe system for the opioid overdose antidote.

Hospira Inc., which is a Pfizer company, said the potential presence of embedded and loos particulate matter could cause a patient to experience adverse effects such as irritation, allergic reactions, pulmonary dysfunction or others.

Any product-related adverse events may be reported on FDA's MedWatch Adverse Event Reporting program.

And now, with the Naloxone getting recalled from the market, it may become hard to deal with the opioid epidemic which claims thousands of lives each day.

See the full recall details.


Exposure to these particulates could have adverse health effects on users of Naloxone.

According to the company, the risk of developing adverse events is low, and that risk is reduced because the product's label directs users to visually inspect the product prior to administration.

The recalled lots were distributed nationwide to wholesalers, distributors, and hospitals in the United States, Puerto Rico, and Guam from February 2017 to February 2018.

Affected products are intended for intravenous (IV) use, intramuscular use and subcutaneous use only, FDA said.

When administered, Naloxone can quickly restore normal respiration to someone whose breathing has slowed or stopped due to opioids.

Other reports by Iphone Fresh

Discuss This Article

FOLLOW OUR NEWSPAPER